STAAR Surgical To Present At Upcoming Investor Conferences

          STAAR Surgical To Present At Upcoming Investor Conferences

~Stephens Fall Investment Conference on November 13

~~CanaccordGenuity Medical Technology & Diagnostics Forum on November 14

PR Newswire

MONROVIA, Calif., Nov. 5, 2013

MONROVIA, Calif., Nov. 5, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ:
STAA), a leading developer, manufacturer and marketer of minimally invasive
ophthalmic products, today announced that it will participate in two upcoming
investor conferences to review the Company's recent financial results and
business developments with investors and interested parties.

Barry Caldwell, President and CEO, and Steve Brown, CFO, will present at the
Stephens Fall Investment Conference at the New York Palace Hotel on Wednesday,
November 13 at 9:00 a.m. ET.

The Company will also participate in a fireside chat at the CanaccordGenuity
Medical Technology & Diagnostics Forum in New York at the Westin Grand Central
on Thursday, November 14, 2013 at 9:00 a.m. ET.

STAAR will offer live webcasts of both these events on the Company's website,, under Investor Information. The Stephens presentation will
include audio with slides. The CanaccordGenuity fireside format provides audio
only. An archived replay of the both these events will be available for 90
days, also at

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25
years, designs, develops, manufactures and markets implantable lenses for the
eye and delivery systems therefor. All of these lenses are foldable, which
permits the surgeon to insert them through a small incision. STAAR's lens used
in refractive surgery as an alternative to LASIK is called an Implantable
Collamer® Lens or "ICL." A lens used to replace the natural lens after
cataract surgery is called an intraocular lens or "IOL." Over 375,000 Visian
ICLs have been implanted to date; to learn more about the ICL go to: STAAR has approximately 300 full time employees and
markets lenses in over 60 countries. Headquartered in Monrovia, CA, it
manufactures in the following locations: Nidau, Switzerland; Aliso Viejo, CA;
and Monrovia, CA. For more information, please visit the Company's website at

Collamer® is the registered trademark for STAAR's proprietary biocompatible
collagen copolymer lens material.

CONTACT: Investors  Media
         EVC Group                    EVC Group
         Doug Sherk, 415-652-9100    Janine McCargo
         Leigh Salvo, 415-568-9348 646-688-0425

SOURCE STAAR Surgical Company

Press spacebar to pause and continue. Press esc to stop.